These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 28242493)

  • 1. C. elegans as a model system to accelerate discovery for Parkinson disease.
    Martinez BA; Caldwell KA; Caldwell GA
    Curr Opin Genet Dev; 2017 Jun; 44():102-109. PubMed ID: 28242493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C. elegans as a genetic model system to identify Parkinson's disease-associated therapeutic targets.
    Vistbakka J; VanDuyn N; Wong G; Nass R
    CNS Neurol Disord Drug Targets; 2012 Dec; 11(8):957-64. PubMed ID: 23244419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards Understanding Neurodegenerative Diseases: Insights from
    Wu Y; Chen Y; Yu X; Zhang M; Li Z
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Traversing a wormhole to combat Parkinson's disease.
    Caldwell GA; Caldwell KA
    Dis Model Mech; 2008; 1(1):32-6. PubMed ID: 19048050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurodegenerative disorders: insights from the nematode Caenorhabditis elegans.
    Dimitriadi M; Hart AC
    Neurobiol Dis; 2010 Oct; 40(1):4-11. PubMed ID: 20493260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caenohabditis elegans in Parkinson's disease drug discovery: addressing an unmet medical need.
    Nass R; Merchant KM; Ryan T
    Mol Interv; 2008 Dec; 8(6):284-93. PubMed ID: 19144901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C. elegans as a model organism to investigate molecular pathways involved with Parkinson's disease.
    Harrington AJ; Hamamichi S; Caldwell GA; Caldwell KA
    Dev Dyn; 2010 May; 239(5):1282-95. PubMed ID: 20108318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling human diseases in Caenorhabditis elegans.
    Markaki M; Tavernarakis N
    Biotechnol J; 2010 Dec; 5(12):1261-76. PubMed ID: 21154667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using C. elegans as a model for neurodegenerative diseases: Methodology and evaluation.
    Caldero-Escudero E; Romero-Sanz S; De la Fuente S
    Methods Cell Biol; 2024; 188():1-34. PubMed ID: 38880519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caenorhabditis elegans as a model system for Parkinson's disease.
    Schmidt E; Seifert M; Baumeister R
    Neurodegener Dis; 2007; 4(2-3):199-217. PubMed ID: 17596715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling dopamine neuron degeneration in Caenorhabditis elegans.
    Tucci ML; Harrington AJ; Caldwell GA; Caldwell KA
    Methods Mol Biol; 2011; 793():129-48. PubMed ID: 21913098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling neurodegenerative diseases in Caenorhabditis elegans.
    Li J; Le W
    Exp Neurol; 2013 Dec; 250():94-103. PubMed ID: 24095843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caenorhabditis elegans as a model system for human diseases.
    Markaki M; Tavernarakis N
    Curr Opin Biotechnol; 2020 Jun; 63():118-125. PubMed ID: 31951916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights from Caenorhabditis elegans on the role of metals in neurodegenerative diseases.
    Martinez-Finley EJ; Avila DS; Chakraborty S; Aschner M
    Metallomics; 2011 Mar; 3(3):271-9. PubMed ID: 21210060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variation in neurodegenerative diseases and its accessibility in the model organism Caenorhabditis elegans.
    Wang YA; Kammenga JE; Harvey SC
    Hum Genomics; 2017 May; 11(1):12. PubMed ID: 28545550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A predictable worm: application of Caenorhabditis elegans for mechanistic investigation of movement disorders.
    Dexter PM; Caldwell KA; Caldwell GA
    Neurotherapeutics; 2012 Apr; 9(2):393-404. PubMed ID: 22403010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From bugs to bedside: functional annotation of human genetic variation for neurological disorders using invertebrate models.
    Mew M; Caldwell KA; Caldwell GA
    Hum Mol Genet; 2022 Oct; 31(R1):R37-R46. PubMed ID: 35994032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling Age-Associated Neurodegenerative Diseases in Caenorhabditis elegans.
    Palikaras K; Tavernarakis N
    J Vis Exp; 2020 Aug; (162):. PubMed ID: 32865526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The contribution of
    Liang JJH; McKinnon IA; Rankin CH
    J Neurogenet; 2020; 34(3-4):527-548. PubMed ID: 32772603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caenorhabditis elegans as a Model to Study the Molecular and Genetic Mechanisms of Drug Addiction.
    Engleman EA; Katner SN; Neal-Beliveau BS
    Prog Mol Biol Transl Sci; 2016; 137():229-52. PubMed ID: 26810004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.